Natalia Bello

803 total citations
31 papers, 528 citations indexed

About

Natalia Bello is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Natalia Bello has authored 31 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Natalia Bello's work include Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Systemic Lupus Erythematosus Research (10 papers). Natalia Bello is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Systemic Lupus Erythematosus Research (10 papers). Natalia Bello collaborates with scholars based in Spain, United States and United Kingdom. Natalia Bello's co-authors include Esperanza Naredo, I. Monteagudo, Luis Carreño, Peter C. Taylor, Gerd R Burmester, Maxime Dougados, Juan Carlos Nieto‐González, Lara Valor, Lina Martínez‐Estupiñán and Anna Moltó and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Natalia Bello

30 papers receiving 523 citations

Peers

Countries citing papers authored by Natalia Bello

Since Specialization

Citations

This map shows the geographic impact of Natalia Bello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Bello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Bello more than expected).

Fields of papers citing papers by Natalia Bello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Bello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Bello. The network helps show where Natalia Bello may publish in the future.

Co-authorship network of co-authors of Natalia Bello

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Bello. A scholar is included among the top collaborators of Natalia Bello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Bello. Natalia Bello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events 2025 ·Dermatology and Therapy ·Mark Lebwohl, Atul Deodhar, Sergio Schwartzman, Carlo Salvarani, (unknown), Natalia Bello, (unknown), (unknown), (unknown), Marcus Ngantcha, Proton Rahman, Kim Papp, Joseph F. Merola, Alice B. Gottlieb, Andrew Blauvelt	2
2	The effect of ixekizumab treatment on MRI sacroiliac joint structural lesions in patients with radiographic axial spondyloarthritis: post-hoc analysis of a 52-week, randomised, placebo-controlled trial with an active reference arm 2025 ·The Lancet Rheumatology ·Walter P. Maksymowych, R. Lambert, Rebecca Bolce, Natalia Bello, Baojin Zhu, Jeffrey Lisse, Mikkel Østergaard	2
3	Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study 2024 ·Lara D. Veeken ·(unknown), Peter C. Taylor, Daniel Aletaha, Raimón Sanmartí, Tsutomu Takeuchi, Daojun Mo, Ewa Haładyj, Natalia Bello, (unknown), Ying Fang, Maxime Dougados	4
4	Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study 2024 ·Rheumatology and Therapy ·Abhijeet Danve, Aisha Vadhariya, Jeffrey Lisse, (unknown), (unknown), Natalia Bello, Catherine Bakewell	2
5	Polypharmacy and Drug Interactions in the COVID-19 Pandemic 2023 ·SHILAP Revista de lepidopterología ·(unknown), Guillermo Alberto Keller, Natalia Bello, Francisco Azzato, Roberto A. Díez, Guido Giunti	1
6	Systematic Literature Review and Meta-analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus 2022 ·Rheumatology and Therapy ·Natalia Bello, Kristin J. Meyers, Jennifer K. Workman, José S Marcano Belisario, Ricard Cervera	15
7	A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus 2022 ·Rheumatology and Therapy ·Thomas Dörner, Edward M Vital, Sarah Ohrndorf, Rieke Alten, Natalia Bello, Ewa Haładyj, Gerd R Burmester	16
8	P196 Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis 2022 ·Lara D. Veeken ·Peter C. Taylor, Tsutomu Takeuchi, Gerd R Burmester, Patrick Durez, Josef S Smolen, Walter Deberdt, Jinglin Zhong, (unknown), Natalia Bello, Kevin Winthrop	1
9	Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study 2022 ·Advances in Therapy ·Natalia Bello, Julie Birt, Jennifer K. Workman, (unknown), (unknown), Michelle Petri	8
10	Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database 2021 ·Annals of the Rheumatic Diseases ·Peter C. Taylor, Tsutomu Takeuchi, Gerd R Burmester, Patrick Durez, Josef S Smolen, Walter Deberdt, Maher Issa, (unknown), Natalia Bello, Kevin Winthrop	106
11	Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis 2021 ·Rheumatology and Therapy ·D. Freites, Alfredo Madrid-García, Leticia León, Gloria Candelas, Mercedes Núñez, Natalia Bello, Silvia Díaz‐Cerezo, Benjamín Fernández‐Gutiérrez, Lydia Abásolo, Luis Rodríguez‐Rodríguez	12
12	Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey 2021 ·Rheumatology and Therapy ·Julie Birt, (unknown), (unknown), (unknown), Paul Swinburn, (unknown), (unknown), Natalia Bello, (unknown), Maria Silk, Laure Delbecque, Diane L. Kamen, Anca Askanase	10
13	To what extend is nail ultrasound discriminative between psoriasis, psoriatic arthritis and healthy subjects? 2018 ·Rheumatology International ·Esperanza Naredo, I. Janta, Ofelia Baniandrés, Lara Valor, Michelle Hinojosa, Natalia Bello, (unknown), Jesús Garrido	21
14	Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis 2016 ·Arthritis Research & Therapy ·Natalia Bello, Adrien Etcheto, (unknown), Maxime Dougados, Anna Moltó	59
15	Increase in IS 256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants 2016 ·Infection Genetics and Evolution ·(unknown), (unknown), Beatriz Perazzi, Natalia Bello, Àngela Famiglietti, Marta Mollerach	11
16	Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission? 2015 ·Rheumatology International ·I. Janta, Lara Valor, Inmaculada de la Torre, Lina Martínez‐Estupiñán, Juan Carlos Nieto‐González, J.G. Ovalles-Bonilla, Julia Martínez‐Barrio, Natalia Bello, Michelle Hinojosa, María Montoro, Carlos González, J. Lόpez-Longo, I. Monteagudo, Luis Carreño, Esperanza Naredo	12
17	Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis 2015 ·Lara D. Veeken ·Esperanza Naredo, Lara Valor, Inmaculada de la Torre, María Montoro, Natalia Bello, Julia Martínez‐Barrio, Lina Martínez‐Estupiñán, Juan Carlos Nieto‐González, J.G. Ovalles-Bonilla, Diana Hernández-Flórez, Carlos González, Francisco Javier López‐Longo, I. Monteagudo, Luis Carreño	89
18	Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment 2015 ·Clinical Rheumatology ·I. Janta, Lina Martínez‐Estupiñán, Lara Valor, María Montoro, (unknown), (unknown), Natalia Bello, Diana Hernández-Flórez, Michelle Hinojosa, Julia Martínez‐Barrio, Juan Carlos Nieto‐González, J.G. Ovalles-Bonilla, Carlos González, Francisco Javier López‐Longo, I. Monteagudo, Esperanza Naredo, Luis Carreño	15
19	Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis? 2014 ·Lara D. Veeken ·Esperanza Naredo, Michelle Hinojosa, Lara Valor, Diana Hernández-Flórez, (unknown), (unknown), (unknown), Natalia Bello, María Montoro, Juan Carlos Nieto‐González, Carlos González, Francisco Javier López‐Longo, I. Monteagudo, Luis Carreño	3
20	Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography 2013 ·Lara D. Veeken ·I. Janta, Esperanza Naredo, Lina Martínez‐Estupiñán, (unknown), Inmaculada de la Torre, L. Valor, (unknown), Natalia Bello, (unknown), Carlos González, (unknown), I. Monteagudo, María Montoro, Luis Carreño	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact